tiprankstipranks
Advertisement
Advertisement
GH Research price target lowered to $65 from $70 at H.C. Wainwright
PremiumThe FlyGH Research price target lowered to $65 from $70 at H.C. Wainwright
16d ago
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
Premium
The Fly
GH Research price target raised to $35 from $25 at Cantor Fitzgerald
20d ago
GH Research price target lowered to $39 from $42 at Citizens
Premium
The Fly
GH Research price target lowered to $39 from $42 at Citizens
20d ago
GH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
PremiumCompany AnnouncementsGH Research Posts Wider Q1 2026 Loss as R&D and Admin Costs Rise
21d ago
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
Premium
Company Announcements
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes
22d ago
GH Research to Attend APA Annual Meeting in San Francisco in May 2026
Premium
Company Announcements
GH Research to Attend APA Annual Meeting in San Francisco in May 2026
22d ago
Trump to sign order on psychedelic used for PTSD, CBS News says
PremiumThe FlyTrump to sign order on psychedelic used for PTSD, CBS News says
2M ago
Psychedelic: Compass Pathways, NRx Pharma report earnings results
Premium
The Fly
Psychedelic: Compass Pathways, NRx Pharma report earnings results
2M ago
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
Premium
Company Announcements
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100